Amiodarone's major metabolite, desethylamiodarone, induces apoptosis in human cervical cancer cells

Canadian Journal of Physiology and Pharmacology
Zita BognarBalazs Sumegi

Abstract

Previously, we found that desethylamiodarone (DEA) may have therapeutic potentiality in bladder cancer. In this study, we determined its effects on human cervical cancer cells (HeLa). Cell viability was evaluated by Muse Cell Count & Viability Assay; cell apoptosis was detected by Muse Annexin V & Dead Cell Assay. Cell cycle was flow cytometrically determined by Muse Cell Cycle Kit and the morphological changes of the cells were observed under a fluorescence microscope after Hoechst 33342 staining. The changes in the expression levels of apoptosis-related proteins in the HeLa cells were assessed by immunoblot. Our results showed that DEA significantly inhibited the proliferation and viability of HeLa cells and induced apoptosis in vitro in dose-dependent and also in cell cycle-dependent manner because DEA induced G0/G1 phase arrest in the HeLa cell line. We found that DEA treatment downregulated the expression of phospho-Akt and phospho-Bad. In addition, DEA could downregulate expression of Bcl-2, upregulate Bax, and induce cytochrome c release. Our results indicate that DEA might have significance as an anti-tumor agent against human cervical cancer.

References

Jan 1, 1991·American Heart Journal·J S Wilson, P J Podrid
Sep 1, 1989·Toxicology and Applied Pharmacology·J M DanielsT E Massey
Oct 1, 1983·American Heart Journal·D W HoltG C Storey
Apr 15, 1997·Proceedings of the National Academy of Sciences of the United States of America·Y T HsuR J Youle
Jun 29, 2000·Clinical Pharmacology and Therapeutics·P T PollakS L Shafer
Nov 15, 2002·Developmental Cell·Andreas Bergmann
Sep 13, 2003·The Journal of Pharmacology and Experimental Therapeutics·Gabor VarbiroFerenc Gallyas
Aug 3, 2004·Science·Douglas R Green, Guido Kroemer
Apr 1, 2005·Nature·Andrew Halestrap
Apr 9, 2008·European Journal of Obstetrics, Gynecology, and Reproductive Biology·Xiao-Yan ZhangHong Sun
Nov 13, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·UNKNOWN Chemoradiotherapy for Cervical Cancer Meta-Analysis Collaboration
Feb 12, 2009·Hepatology Research : the Official Journal of the Japan Society of Hepatology·Jing-Song ChenLong-Juan Zhang
May 20, 2009·Cancer·Sujana MovvaClaire Verschraegen
Sep 2, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Bradley J MonkDavid Cella
Feb 26, 2011·International Journal of Cancer. Journal International Du Cancer·Jacques FerlayDonald Maxwell Parkin
Apr 14, 2011·Current Cancer Drug Targets·Doris Mangiaracina Benbrook, Chioniso Patience Masamha
Apr 17, 2014·Current Medicinal Chemistry·Jiezhong ChenChen Chen
Dec 3, 2014·Biochimica Et Biophysica Acta·Stine Aske DanielsenRagnhild A Lothe
Jan 9, 2016·CA: a Cancer Journal for Clinicians·Rebecca L SiegelAhmedin Jemal

❮ Previous
Next ❯

Related Concepts

Related Feeds

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Related Papers

Journal of Huazhong University of Science and Technology. Medical Sciences = Hua Zhong Ke Ji Da Xue Xue Bao. Yi Xue Ying De Wen Ban = Huazhong Keji Daxue Xuebao. Yixue Yingdewen Ban
Tao XiangShi-Xuan Wang
Journal of Huazhong University of Science and Technology. Medical Sciences = Hua Zhong Ke Ji Da Xue Xue Bao. Yi Xue Ying De Wen Ban = Huazhong Keji Daxue Xuebao. Yixue Yingdewen Ban
Amal BanafaGuang-Yuan He
© 2022 Meta ULC. All rights reserved